The popular drugs, originally developed to treat diabetes, are being used more and more in the United States to help obese and overweight patients lose weight.
Many people who rely on power wheelchairs to get around will soon have the option to let onboard AI negotiate obstacles, adjust speeds and avoid collisions.
Improving care for patients with cardiac amyloidosis has emerged as one of the hottest topics in cardiology. Pfizer helped kickstart that trend in 2019 when it gained FDA approval for two separate medications for the rare, but potentially fatal disease.